mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.26 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.1 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.1 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.23 |
0.1 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |